Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-16

FDA Approved: ROPINIROLE HYDROCHLORIDE — Supplemental Application (SOLCO HEALTHCARE US, LLC)

View source ↗

Summary

FDA approved a supplemental application for ropinirole hydrochloride from Solco Healthcare US, LLC, approving an additional generic version under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole hydrochloride (ropinirole hydrochloride)

Snippet

SUPPL AP for ROPINIROLE HYDROCHLORIDE (ROPINIROLE HYDROCHLORIDE)